The BCN-AIM research projects aim to understand how environmental factors, lifestyle choices, and genetic predispositions interact to affect health throughout life, focusing on major health issues like obesity, type 2 diabetes, cardiovascular diseases (CVD), and aging-related health problems.
Primary goals include developing advanced AI models to improve early diagnosis and prognosis of CVDs, the leading cause of death worldwide, accounting for about one-third of global deaths. Another aim is to create personalized healthcare solutions by analyzing diverse data sources, including medical imaging, ECG data, lifestyle habits, and medication histories.
These projects are scientifically grounded in the complexity and variability of CVDs and chronic conditions. Conditions like heart failure have diverse causes, symptoms, and progression patterns, making them challenging to diagnose and treat effectively. AI models can analyze large datasets to identify patterns and risk factors not evident through traditional methods. For example, AI can detect subtle changes in ECG data indicating early stages of heart disease, enabling timely intervention. Additionally, the projects will adopt a life-course approach, using longitudinal data to study how various exposures and behaviors over time influence health outcomes. This comprehensive approach is essential for understanding the root causes of diseases and developing prevention strategies.
The public health impact of BCN-AIM projects is expected to be substantial. By improving the accuracy and timeliness of CVD diagnosis and prognosis, the projects aim to enhance patient outcomes and reduce mortality rates. Personalized healthcare solutions, developed through AI analysis of comprehensive data, promise to tailor treatments to individual patients’ needs, optimizing clinical outcomes and improving quality of life. Additionally, these projects seek to inform and transform health policies and practices by providing deeper insights into disease prevention and health promotion. Integrating AI and thorough data analysis, the BCN-AIM projects aim to drive significant improvements in public health, support the development of more effective and personalized healthcare solutions, and contribute to the advancement of healthcare delivery systems within European and low-resource regions.
The project duration is flexible due to the iterative nature of generating, testing, and refining hypotheses. The initial 3-year plan (36 months) is designed to validate initial hypotheses, discard those that fail, and develop robust models. This timeframe also allows for ample opportunity to produce and publish findings, ensuring a comprehensive and thorough research process. Annual reports will detail the evolution of research lines, document any deviations, and outline both discarded and successful hypotheses.